| Literature DB >> 25955349 |
Mario Barbosa1, Isabel Prada-López2, Maximiliano Álvarez3, Barbas Amaral4, Casares-De-Cal María de los Angeles2, Inmaculada Tomás2.
Abstract
OBJECTIVES: To investigate the development of post-extraction bacteraemia (PEB) after the prophylactic use of chlorhexidine (CHX). PATIENTS AND METHODS: A total of 201 patients who underwent a tooth extraction were randomly distributed into four groups: 52 received no prophylaxis (CONTROL), 50 did a mouthwash with 0.2% CHX before the tooth extraction (CHX-MW), 51 did a mouthwash with 0.2% CHX and a subgingival irrigation with 1% CHX (CHX-MW/SUB_IR) and 48 did a mouthwash with 0.2% CHX and a continuous supragingival irrigation with 1% CHX (CHX-MW/SUPRA_IR). Peripheral venous blood samples were collected at baseline, 30 seconds after performing the mouthwash and the subgingival or supragingival irrigation, and at 30 seconds and 15 minutes after completion of the tooth extraction. Blood samples were analysed applying conventional microbiological cultures under aerobic and anaerobic conditions performing bacterial identification of the isolates.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25955349 PMCID: PMC4425363 DOI: 10.1371/journal.pone.0124249
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of the study with enrollment, allocation, follow-up and analysis of participants.
Fig 2Protocol for the collection of blood samples for microbiological processing.
Clinical characteristics of the four study groups.
| CLINICAL MEASURES | STUDY GROUPS | ||||
|---|---|---|---|---|---|
| TOTALn (%) | CONTROLn (%) | CHX-MWn (%) | CHX-MW/SUB_IRn (%) | CHX-MW/SUPRA_IRn (%) | |
|
| 46.7 ± 16.7 | 42.4 ± 17.8 | 48.7 ± 17.0 | 48.7 ± 17.1 | 47.4 ± 14.4 |
|
| |||||
| Men | 87 (43.3%) | 21 (40.4%) | 14 (28.0%) | 25 (49.0%) | 27 (56.2%) |
| Women | 114 (56.7%) | 31 (59.6%) | 36 (72.0%) | 26 (51.0%) | 21 (43.8%) |
|
| |||||
| Grade 0 | 15 (7.5%) | 9 (17.3%) | 2 (4.0%) | 2 (3.9%) | 2 (4.2%) |
| Grade 1 | 68 (33.8%) | 19 (36.6%) | 12 (24.0%) | 18 (35.3%) | 19 (39.5%) |
| Grade 2 | 95 (47.3%) | 22 (42.3%) | 25 (50.0%) | 23 (45.1%) | 25 (52.1%) |
| Grade 3 | 23 (11.4%) | 2 (3.8%) | 11 (22.0%) | 8 (15.7%) | 2 (4.2%) |
|
| |||||
| Incisor or Canine | 47 (23.4%) | 9 (17.3%) | 13 (26.0%) | 9 (17.6%) | 16 (33.3%) |
| Premolar or Molar | 154 (76.6%) | 43 (82.7%) | 37 (74.0%) | 42 (82.4%) | 32 (66.7%) |
|
| |||||
| Periodontitis | 37 (18.4%) | 6 (11.5%) | 16 (32.0%) | 7 (13.7%) | 8 (16.7%) |
| Caries or others | 164 (81.6%) | 46 (88.5%) | 34 (68.0%) | 44 (86.3%) | 40 (83.3%) |
SD = standard deviation.
Fig 3Prevalence of bacteraemia at baseline, after the mouthwash with 0.2% CHX, after a mouthwash with 0.2% CHX/subgingival irrigation with 1% CHX, after a mouthwash with 0.2% CHX/supragingival irrigation with 1% CHX and after tooth extraction in the four study groups: CONTROL group (n = 52 patients), CHX-MW group (n = 50 patients), CHX-MW/SUB_IR group (n = 51 patients) and CHX-MW/SUPRA_IR group (n = 48 patients).
Prevalence of bacteria identified in the positive blood cultures in the CONTROL group (n = 46 isolates), CHX-MW group (n = 35 isolates), CHX-MW/SUB_IR group (n = 33 isolates) and CHX-MW/SUPRA_IR group (n = 42).
| BACTERIA | CONTROL% of isolates | CHX-MW% of isolates | CHX-MW/SUB_IR% of isolates | CHX-MW/SUPRA_IR% of isolates |
|---|---|---|---|---|
|
| 72 | 71 | 79 | 69 |
|
| 6 | 0 | 0 | 2 |
|
| 2 | 0 | 0 | 7 |
| Obligate anaerobes | 11 | 17 | 12 | 2 |
| HACEK Group | 0 | 6 | 0 | 2 |
| Other bacteria | 9 | 6 | 9 | 17 |
CHX = chlorhexidine; MW = mouthwash; SUB = subgingival; SUPRA = supragingival; IR = irrigation; HACEK Group = acronymic designation for a group of gram-negative bacteria that includes Haemophilus spp., Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens and Kingella spp.
Forty six isolates in the CONTROL group blood cultures
33 viridans group streptococci (20 S. mitis group, 6 S. anginosus group, 3 S. mutans group, 3 S. salivarius group and 1 S. bovis group); 3 Staphylococcus spp. (1 S. hominis and 2 S. simulans); 1 Neisseria spp. (1 N. cinerea); 5 obligate anaerobes (2 Propionibacterium spp. [1 P. acnes, 1 Propionibacterium spp.], 1 Peptostreptococcus spp., 1 Fusobacterium spp. and 1 Bacillus spp.); and 4 other bacteria (2 Actinomyces spp. and 2 Micrococcus spp.).
Thirty five isolates in the CHX-MW group blood cultures
24 viridans group streptococci (16 S. mitis group, 4 S. anginosus group, 2 S. mutans group and 2 S. salivarius group) and 1 Streptococcus non-viridans group; 6 obligate anaerobes (2 Prevotella spp., 2 Fusobacterium spp., 1 Eubacterium spp. and 1 Bacillus spp.); 2 HACEK group (2 Eikenella spp.); and 2 other bacteria (2 Actinomyces spp.).
Thirty three isolates in the CHX-MW/SUB_IR group blood cultures
25 viridans group streptococci (9 S. mitis group, 10 S. anginosus group and 6 S. salivarius group) and 1 Streptococcus non-viridans group; 4 obligate anaerobes (1 Peptostreptococcus spp., 1 Prevotella spp., 1 Fusobacterium spp. and 1 Bacillus spp.); and 3 other bacteria (3 Actinomyces spp.).
Forty two isolates in the CHX-MW/SUPRA_IR group blood cultures
29 viridans group streptococci (25 S. mitis group, 2 S. anginosus group and 2 S. salivarius group); 1 Staphylococcus spp. (coagulase-negative); 3 Neisseria spp. (3 N. sicca); 1 obligate anaerobe (1 Bacillus spp.); 1 HACEK group (1 Haemophilus spp.) and 7 other bacteria (1 Corynebacterium spp. and 6 Actinomyces spp.).